CORT - CIK 0001088856
CORCEPT THERAPEUTICS INC (CORT) reported revenue of $761.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $761.41M | +12.8% |
| FY 2024 | $675.04M | +39.9% |
| FY 2023 | $482.38M | +20.0% |
| FY 2022 | $401.86M | +9.8% |
| FY 2021 | $365.98M | +3.4% |
| FY 2020 | $353.87M | +15.5% |
| FY 2019 | $306.49M | +22.0% |
| FY 2018 | $251.25M | +57.8% |
| FY 2017 |
CORCEPT THERAPEUTICS INC (CORT) reported revenue of $761.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2009 and fiscal 2025, CORCEPT THERAPEUTICS INC's revenue grew from $29.00K to $761.41M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $159.20M |
| +95.8% |
| FY 2016 | $81.32M | +280317.2% |
| FY 2009 | $29.00K | - |